Taken together, these findings suggest an important role of suppressing AT1R in patient with colon cancer and led us to investigate whether an AT1R blocker may inhibit CRC cell growth either alone or in combination with other chemotherapeutic drugs. This evidence concerns the gene AGTR1 and colonic neoplasm.